z-logo
open-access-imgOpen Access
PI3K/AKT/mTOR Signaling-Mediated Neuropeptide VGF in the Hippocampus of Mice Is Involved in the Rapid Onset Antidepressant-Like Effects of GLYX-13
Author(s) -
Lu Yang,
Chuang Wang,
Zhancheng Xue,
Chenli Li,
Junfang Zhang,
Xin Zhao,
Aiming Liu,
Qinwen Wang,
Wenhua Zhou
Publication year - 2015
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyu110
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , behavioural despair test , ly294002 , hippocampus , phosphatidylinositol , neuroprotection , kinase , antidepressant , endocrinology , pharmacology , signal transduction , medicine , biology , microbiology and biotechnology
VGF (nonacryonimic) and phosphatidylinositol 3-kinase (PI3K)/AKT (also known as protein kinase B, PKB)/mammalian target of rapamycin (mTOR) signaling play pivotal roles in depression. However, whether phosphatidylinositol 3-kinase/AKT/mTOR signaling-mediated VGF participates in rapid-acting antidepressant-like actions of GLYX-13 is unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom